{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T23:04:31Z","timestamp":1648940671038},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s11596-010-0663-6","type":"journal-article","created":{"date-parts":[[2010,12,21]],"date-time":"2010-12-21T06:59:45Z","timestamp":1292914785000},"page":"809-814","source":"Crossref","is-referenced-by-count":0,"title":["Inhibitory effect of PPAR\u03b3 agonist on the proliferation of human pterygium fibroblasts"],"prefix":"10.1007","volume":"30","author":[{"given":"Yuan","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingchang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,22]]},"reference":[{"issue":"3","key":"663_CR1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/08820530902801106","volume":"24","author":"J. Mauro","year":"2009","unstructured":"Mauro J, Foster CS. Pterygia: pathogenesis and the role of subconjunctival bevacizumab intreatment. Semin Ophthalmol, 2009,24(3):130\u2013134","journal-title":"Semin Ophthalmol"},{"issue":"6","key":"663_CR2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000151740","volume":"222","author":"O. Yalcin Tok","year":"2008","unstructured":"Yalcin Tok O, Burcu Nurozier A, Ergun G, et al. Topical cyclosporine A in the prevention of pterygium recurrence. Ophthalmologica, 2008, 222(6):391\u2013396","journal-title":"Ophthalmologica"},{"issue":"3","key":"663_CR3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1172\/JCI27958","volume":"116","author":"L. Michalik","year":"2006","unstructured":"Michalik L, Wahli W. Involvement of PPAR nuclear receptors in tissue injury and wound repair. J Clin Invest, 2006,116(3):598\u2013606","journal-title":"J Clin Invest"},{"issue":"1","key":"663_CR4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1681\/ASN.2005030257","volume":"17","author":"Y. Li","year":"2006","unstructured":"Li Y, Wen X, Spataro BC, et al. Hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator activated receptor-\u03b3 agonists. J Am Soc Nephrol, 2006,17(1):54\u201365","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"663_CR5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10637-008-9161-0","volume":"27","author":"X. Xiong","year":"2009","unstructured":"Xiong X, Ye Y, Fu L, et al. Antitumor activity of a novel series of alpha-aryloxy-alpha-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines. Invest New Drugs, 2009,27(3): 223\u2013232","journal-title":"Invest New Drugs"},{"issue":"8","key":"663_CR6","first-page":"2154","volume":"41","author":"A. Solomon","year":"2000","unstructured":"Solomon A, Li DQ, Lee SB, et al. Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines. Invest Ophthalmol Vis Sci, 2000, 41(8):2154\u20132163","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"663_CR7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/02713689408999878","volume":"13","author":"N. Dushku","year":"1994","unstructured":"Dushku N, Reid TW. Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells. Curr Eye Res, 1994,13(7):473\u2013481","journal-title":"Curr Eye Res"},{"issue":"9","key":"663_CR8","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s004170050144","volume":"236","author":"L. Kria","year":"1998","unstructured":"Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol, 1998, 236(9):702\u2013708","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"663_CR9","first-page":"215","volume":"22","author":"A. Tassy","year":"1999","unstructured":"Tassy A, Ribe D. Thiotepa eyedrops for prevention of pterygium recurrence: 18 years of use. J Fr Ophtalmol, 1999,22(2):215\u2013219","journal-title":"J Fr Ophtalmol"},{"issue":"1","key":"663_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1590\/S0004-27492007000100014","volume":"70","author":"M.M. Viveiros","year":"2007","unstructured":"Viveiros MM, Schellini SA, Candeias J, et al. Exposure of normal Tenon\u2019s capsule fibroblasts from pterygium to 5-fluorouracil and Mitomycin C. Arq Bras Oftalmol, 2007, 70(1):73\u201377","journal-title":"Arq Bras Oftalmol"},{"issue":"2","key":"663_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1590\/S0004-27492009000200007","volume":"72","author":"V.G. Valezi","year":"2009","unstructured":"Valezi VG, Schellini SA, Viveiros MM, et al. Safety and efficacy of intraoperative 5-fluorouracil infiltration in pterygium treatment. Arq Bras Oftalmol, 2009,72(2):169\u2013173","journal-title":"Arq Bras Oftalmol"},{"issue":"3","key":"663_CR12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000055660","volume":"33","author":"J.S. Lee","year":"2001","unstructured":"Lee JS, Oum BS, Lee SH. Mitomycin C influence on inhibition of cellular proliferation and subsequent synthesis of type I collagen and laminin in primary and recurrent pterygia. Ophthalmic Res, 2001,33(3):140\u2013146","journal-title":"Ophthalmic Res"},{"issue":"5","key":"663_CR13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0161-6420(03)00091-5","volume":"110","author":"E.D. Donnenfeld","year":"2003","unstructured":"Donnenfeld ED, Perry HD, Fromer S, et al. Subconjunctival mitomycin C as adjunctive therapy before pterygium excision. Ophthalmology, 2003,110(5): 1012\u20131016","journal-title":"Ophthalmology"},{"issue":"2","key":"663_CR14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1034\/j.1600-0420.1999.770206.x","volume":"77","author":"H. Oguz","year":"1999","unstructured":"Oguz H, Basar E, Gurler B. Intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Acta Ophthalmol Scand, 1999,77(2):147\u2013150","journal-title":"Acta Ophthalmol Scand"},{"issue":"3","key":"663_CR15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0002-9394(14)76738-8","volume":"112","author":"J.P. Dunn","year":"1991","unstructured":"Dunn JP, Seamone CD, Ostler HB, et al. Development of scleral ulceration and calcification after pterygium excision and mitomycin therapy. Am J Ophthalmol, 1991, 112(3):343\u2013344","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"663_CR16","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0161-6420(92)31749-X","volume":"99","author":"R.S. Rubinfeld","year":"1992","unstructured":"Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology, 1992,99(11):1647\u20131654","journal-title":"Ophthalmology"},{"issue":"4","key":"663_CR17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","volume":"36","author":"P.J. Rosenfeld","year":"2005","unstructured":"Rosenfeld PJ, Moshfeghi AA, Puliafito CA, et al. Optical coherence tomography findings after intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthal Surg Lasers Imaging, 2005, 36(4):331\u2013335","journal-title":"Ophthal Surg Lasers Imaging"},{"issue":"3","key":"663_CR18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006982-200603000-00004","volume":"26","author":"R.F. Spaide","year":"2006","unstructured":"Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina, 2006,26(3):275\u2013278","journal-title":"Retina"},{"issue":"7","key":"663_CR19","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/bjo.2008.155291","volume":"93","author":"A.M. Mansour","year":"2009","unstructured":"Mansour AM. Treatment of inflamed or residual pterygial bed. Br J Ophthalmol, 2009,93(7):864\u2013865","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"663_CR20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11596-007-0332-6","volume":"27","author":"M.C. Zhang","year":"2007","unstructured":"Zhang MC, Bian F, Wen C, et al. Inhibitory effect of curcumin on proliferation of human pterygium fibroblasts. J Huazhong Univ Sci Technol [Med Sci], 2007,27(3):339\u2013342","journal-title":"J Huazhong Univ Sci Technol [Med Sci]"},{"issue":"2","key":"663_CR21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.preteyeres.2004.02.002","volume":"23","author":"N. Girolamo Di","year":"2004","unstructured":"Di Girolamo N, Chui J, Coroneo MT, et al. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res, 2004,23(2):195\u2013228","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"663_CR22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00003226-200307000-00015","volume":"22","author":"J. Jin","year":"2003","unstructured":"Jin J, Guan M, Sima J, et al. Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia. Cornea, 2003, 22(5):473\u2013477","journal-title":"Cornea"},{"issue":"6","key":"663_CR23","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1167\/iovs.05-1130","volume":"47","author":"N. Girolamo Di","year":"2006","unstructured":"Di Girolamo N, Wakefield D, Coroneo MT. UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest Ophthalmol Vis Sci, 2006,47(6):2430\u20132437","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"663_CR24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1593\/neo.06433","volume":"8","author":"S. Vignati","year":"2006","unstructured":"Vignati S, Albertini V, Rinaldi A, et al. Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells. Neoplasia, 2006,8(10):851\u2013861","journal-title":"Neoplasia"},{"issue":"5","key":"663_CR25","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1152\/ajpgi.00124.2006","volume":"291","author":"L. Yang","year":"2006","unstructured":"Yang L, Chan CC, Kwon OS, et al. Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis. Am J Physiol Gastrointest Liver Physiol, 2006, 291(5):902\u2013911","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"663_CR26","doi-asserted-by":"crossref","first-page":"83593","DOI":"10.1155\/2007\/83593","volume":"2007","author":"M. Gurnell","year":"2007","unstructured":"Gurnell M. \u2019striking the Right Balance\u2019 in Targeting PPAR\u03b3 in the Metabolic Syndrome: Novel Insights from Human Genetic Studies. PPAR Res, 2007,2007:83593","journal-title":"PPAR Res"},{"issue":"11","key":"663_CR27","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/000348940010901110","volume":"109","author":"Y. Ohta","year":"2000","unstructured":"Ohta Y, Ichimura K. Proliferation markers, proliferating cell nuclear antigen, Ki67, 5-bromo-2\u2032-deoxyuridine, and cyclin D1 in mouse olfactory epithelium. Ann Otol Rhinol Laryngol, 2000,109(11):1046\u20131048","journal-title":"Ann Otol Rhinol Laryngol"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-010-0663-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-010-0663-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-010-0663-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:15:07Z","timestamp":1559394907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-010-0663-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1007\/s11596-010-0663-6","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}